Company Profiles

driven by the PitchBook Platform

Delphinus Medical Technologies

Description

Operator of a medical imaging company designed for screening technology for breast cancer. The company develops, commercializes and provides breast cancer screening solutions to hospitals and imaging clinics as well as builds a three-dimensional full-breast ultrasound imaging device that differentiates benign from malignant masses in breast cancer cases, using a patented technology enabling medical professionals better define and diagnose breast disease and provide better patient experience for women regardless of age, without concern of radiation or discomfort.

2010

Founded

PRIVATE

Status

11-50

Employees

Series C

Latest Deal Type

$40.5M

Latest Deal Amount

$63.5M

Total Amount Raised

Description

Operator of a medical imaging company designed for screening technology for breast cancer. The company develops, commercializes and provides breast cancer screening solutions to hospitals and imaging clinics as well as builds a three-dimensional full-breast ultrasound imaging device that differentiates benign from malignant masses in breast cancer cases, using a patented technology enabling medical professionals better define and diagnose breast disease and provide better patient experience for women regardless of age, without concern of radiation or discomfort.

Website:

www.delphinusmt.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Diagnostic Equipment

Other Industries

Decision/Risk Analysis

Primary Office

45525 Grand River Avenue Novi, MI 48374United States +1 (248) 522-9600
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Delphinus Medical Technologies's full profile, request a free trial.

Delphinus Medical Technologies Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Delphinus Medical Technologies Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Delphinus Medical Technologies Investors (13)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Arboretum VenturesVenture CapitalMinority000 0000000 0000
BeringeaPE/BuyoutMinority000 0000000 0000
Hopen Life Science VenturesVenture CapitalMinority000 0000000 0000
Invest DetroitVenture CapitalMinority000 0000000 0000
Invest MichiganVenture CapitalMinority000 0000000 0000
Arboretum Ventures Venture Capital
Beringea PE/Buyout
Hopen Life Science Ventures Venture Capital
Invest Detroit Venture Capital
Invest Michigan Venture Capital

Delphinus Medical Technologies Executive Team (9)

NameTitleBoard
Seat
Contact
Info
Mark ForchettePresident, Board Member & Chief Executive Officer
Neb Duric Ph.DChief Technology Officer, Technology & Co-Founder
Andrea WallenDirector, Quality and Regulatory Affairs
Heather RoneVice President, Clinical Affairs
Chris SandersVice President, Engineering
Mark Forchette President, Board Member & Chief Executive Officer
Neb Duric Ph.D Chief Technology Officer, Technology & Co-Founder
Andrea Wallen Director, Quality and Regulatory Affairs
Heather Rone Vice President, Clinical Affairs
Chris Sanders Vice President, Engineering

Delphinus Medical Technologies Board Members (8)

NameRepresentingRoleSinceContact
Info
Alicia TorresSelfBoard Member000 0000
Hugo BraunNorth Coast Technology InvestorsCo-Founder000 0000
John NeisVenture InvestorsExecutive Managing Director000 0000
Michael Fulton MDHopen Life Science VenturesManaging Director000 0000
Michael GrossBeringeaManaging Director000 0000
Alicia Torres Board Member Self
Hugo Braun Co-Founder North Coast Technology Investors
John Neis Executive Managing Director Venture Investors
Michael Fulton MD Managing Director Hopen Life Science Ventures
Michael Gross Managing Director Beringea
Request full access to PitchBook